![Patrick Schnegelsberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick Schnegelsberg
Director Ejecutivo en SynCardia Systems LLC .
Cargos activos de Patrick Schnegelsberg
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SynCardia Systems LLC
![]() SynCardia Systems LLC Medical SpecialtiesHealth Technology SynCardia Systems LLC engages in the manufacture of temporary total artificial heart. Its total artificial heart provides immediate, safe blood flow of up to 9.5 L/min through each ventricle. The company was founded by Marvin J. Slepian, Jack G. Copeland, and Richard G. Smith in 2001 and is headquartered in Tucson, AZ. | Director Ejecutivo | - | - |
Acorai AB
![]() Acorai AB Medical SpecialtiesHealth Technology Acorai AB is a Swedish medical device company founded in 2019. The company is based in Stockholm, Sweden. The company is developing a scalable medical device for non-invasive intracardiac pressure monitoring to improve heart failure management for more than 64 million patients worldwide. | Director/Miembro de la Junta | 01/04/2022 | - |
Historial de carrera de Patrick Schnegelsberg
Antiguos cargos conocidos de Patrick Schnegelsberg.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Syntach AB
![]() Syntach AB Medical SpecialtiesHealth Technology Syntach AB is a Swedish company based in Lund that specializes in developing a revolutionary, minimally invasive long-term cardiac support device and mitral valve repair technology for people suffering from severe heart failure. Syntach has close links and extensive cooperation with various institutions at the University of Lund. The company is also developing a minimally-invasive device to correct mitral valve regurgitation, which can be used in combination with the cardiac support device or on a standalone basis. The company was founded in 2012 with the aim of creating an entirely new class of cardiac support devices to improve the care of the rapidly-growing number of people with heart failure. The company was founded by Tor Peters and Jan Otto Solem, who have been the CEOs since incorporation. | Director Ejecutivo | 31/01/2023 | 01/07/2023 |
Scandinavian Real Heart AB
![]() Scandinavian Real Heart AB Medical SpecialtiesHealth Technology Scandinavian Real Heart AB engages in the development of mechanical cardiac pumps. It offers an artificial heart that recreates the flow, pressure, and control of a pumping heart and can be used for patients awaiting heart transplants. The company was founded by Azad Najar, Gunnar Nihlén, and Said Zahrai in 1999 and is headquartered in Västerås, Sweden. | Director/Miembro de la Junta | 01/01/2022 | 07/06/2023 |
Independent Dir/Board Member | 01/01/2022 | 07/06/2023 | |
OCCLUTECH HOLDING AG | Director Ejecutivo | 01/03/2013 | - |
Director de Operaciones | 01/07/2012 | 01/03/2021 | |
Gammacan International, Inc.
![]() Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Director Ejecutivo | 15/04/2006 | 01/11/2008 |
Formación de Patrick Schnegelsberg.
Clark University | Undergraduate Degree |
Harvard University | Graduate Degree |
Harvard Medical School | Undergraduate Degree |
Massachusetts Institute of Technology | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Suecia | 4 |
Israel | 2 |
Operativa
Chief Executive Officer | 4 |
Undergraduate Degree | 3 |
Director/Board Member | 2 |
Sectorial
Health Technology | 7 |
Consumer Services | 4 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
![]() | Health Technology |
Empresas privadas | 5 |
---|---|
Gammacan International, Inc.
![]() Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
Syntach AB
![]() Syntach AB Medical SpecialtiesHealth Technology Syntach AB is a Swedish company based in Lund that specializes in developing a revolutionary, minimally invasive long-term cardiac support device and mitral valve repair technology for people suffering from severe heart failure. Syntach has close links and extensive cooperation with various institutions at the University of Lund. The company is also developing a minimally-invasive device to correct mitral valve regurgitation, which can be used in combination with the cardiac support device or on a standalone basis. The company was founded in 2012 with the aim of creating an entirely new class of cardiac support devices to improve the care of the rapidly-growing number of people with heart failure. The company was founded by Tor Peters and Jan Otto Solem, who have been the CEOs since incorporation. | Health Technology |
SynCardia Systems LLC
![]() SynCardia Systems LLC Medical SpecialtiesHealth Technology SynCardia Systems LLC engages in the manufacture of temporary total artificial heart. Its total artificial heart provides immediate, safe blood flow of up to 9.5 L/min through each ventricle. The company was founded by Marvin J. Slepian, Jack G. Copeland, and Richard G. Smith in 2001 and is headquartered in Tucson, AZ. | Health Technology |
Acorai AB
![]() Acorai AB Medical SpecialtiesHealth Technology Acorai AB is a Swedish medical device company founded in 2019. The company is based in Stockholm, Sweden. The company is developing a scalable medical device for non-invasive intracardiac pressure monitoring to improve heart failure management for more than 64 million patients worldwide. | Health Technology |
Occlutech Holding AG
![]() Occlutech Holding AG Medical SpecialtiesHealth Technology Occlutech Holding AG manufactures cardiac implant products. The firm?s products include Occlutech PLD, Occlutech Figulla Flex II, Sizing Occlutech ASD, Occlutech PDA Occluder, Occlutech Delivery Set and Occlutech Stiff Guide Wire. The company is headquartered in Schaffhausen, Switzerland. | Health Technology |